VXRT - Why Vaxart Soared 109.8% In January
Shares of Vaxart (NASDAQ: VXRT) surged 109.8% in January, according to data provided by S&P Global Market Intelligence , adding onto the colossal 1,530% gain the stock made across all of 2020.
Essentially a penny stock at the start of last year, Vaxart vaulted to the forefront of investor consciousness on the premise that it could develop an effective oral vaccine for COVID-19.
Image source: Getty Images.
For further details see:
Why Vaxart Soared 109.8% In January